Pharma Capital

'We're very fortunate and it's a great honor' - Friday Night's Brayden Sutton on their $7.5mln raise

Brayden Sutton, chief executive of Friday Night Inc (CNSX:TGIF) talks Proactive's Andrew Scott through their raise of $7.5mln from a private placing of debenture units to expand the company's growing operations in Las Vegas, Nevada.

Canaccord Genuity Corp has agreed to act as exclusive agent on the placing.

The company plans to use the net proceeds to expand its growing operations in Las Vegas, and for general corporate purposes.

The closing of the offering is expected to occur on or about July 31 this year.

 

View full TGIF profile

Friday Night Inc. Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.